
OmniAb Investor Relations Material
Latest events

Q3 2024
OmniAb
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from OmniAb Inc
Access all reports
OmniAb Inc. is a biotechnology firm specializing in the discovery and development of therapeutic antibodies. The company operates a unique discovery platform that leverages the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which are engineered to produce antibodies with human sequences. This approach facilitates the development of human therapeutic candidates. The company is headquartered in Emeryville, California, and its shares are listed on the Nasdaq.
Key slides for OmniAb Inc


Q1 2024
OmniAb Inc


Q2 2024
OmniAb Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
OABI
Country
🇺🇸 United States